On the other hand, although multiple mutations in different genes can be detected in most of CMML patients, it is interesting to point out that 91% of patients are characterized by harboring a mutation in at least one of the three most recurrent genes in CMML (TET2, ASXL1, SRSF2), which can be used for diagnostic purposes. The gene discussed is TET2; the disease is chronic myelomonocytic leukemia.